<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is predominantly characterized by pulmonary inflammation. The World Health Organization (WHO) has named the pneumonia caused by this virus as COVID-19 [
 <xref rid="bib1" ref-type="bibr">1</xref>,
 <xref rid="bib2" ref-type="bibr">2</xref>]. Coronaviruses are RNA viruses divided into four genera according to their serotypes and genomic characteristics; SARS-CoV-2 is a novel betacoronavirus [
 <xref rid="bib3" ref-type="bibr">3</xref>]. The main presenting symptoms are fever, fatigue, and dry cough, with dyspnea appearing approximately 1 week later in severe cases. Critical cases may rapidly progress to severe acute respiratory distress syndrome, septic shock, or even death [
 <xref rid="bib4" ref-type="bibr">4</xref>]. Chest CT plays a crucial role in reaching an early diagnosis, ensuring rapid quarantine and treatment, as well as in evaluating therapeutic efficacy. We retrospectively analyzed the imaging and clinical data obtained from a patient who was diagnosed with COVID-19 in our hospital. We also considered the clinical and epidemiological characteristics of the case in order to enhance our understanding of COVID-19.
</p>
